Covered recipient · General Payments record
SETH LEVY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,485.29
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $569.27 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $233.93 | 16 |
| PFIZER INC. | $77.11 | 5 |
| BECTON, DICKINSON AND COMPANY | $40.00 | 1 |
| Novo Nordisk AS | $34.00 | 2 |
| W. L. Gore & Associates, Inc. | $28.42 | 1 |
| Acerta Pharma LLC | $28.37 | 2 |
| Astellas Pharma US Inc | $23.17 | 1 |
| Medtronic, Inc. | $21.83 | 1 |
| IBSA Pharma Inc. | $20.18 | 1 |
| SANOFI PASTEUR INC. | $19.00 | 1 |
| Lilly USA, LLC | $14.93 | 1 |
| Abbott Laboratories | $14.38 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.95 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.38 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124987007 | CMS |
| ABBVIE INC. | $4.98 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168546 | CMS |
| ABBVIE INC. | $20.86 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168548 | CMS |
| ABBVIE INC. | $16.21 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168550 | CMS |
| ABBVIE INC. | $15.83 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168552 | CMS |
| ABBVIE INC. | $13.57 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168554 | CMS |
| ABBVIE INC. | $17.41 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168556 | CMS |
| ABBVIE INC. | $14.62 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168558 | CMS |
| ABBVIE INC. | $16.85 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168560 | CMS |
| ABBVIE INC. | $14.80 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168562 | CMS |
| ABBVIE INC. | $12.12 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168564 | CMS |
| ABBVIE INC. | $16.91 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168566 | CMS |
| ABBVIE INC. | $18.15 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168568 | CMS |
| ABBVIE INC. | $16.92 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168570 | CMS |
| ABBVIE INC. | $11.35 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168572 | CMS |
| ABBVIE INC. | $9.29 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168574 | CMS |
| ABBVIE INC. | $14.06 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104168576 | CMS |
| Astellas Pharma US Inc | $23.17 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139430154 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.00 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104276925 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.37 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105699090 | CMS |
| Becton, Dickinson and Company | $40.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127621164 | CMS |
| IBSA Pharma Inc. | $20.18 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142979855 | CMS |
| Lilly USA, LLC | $14.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135371662 | CMS |
| Medtronic, Inc. | $21.83 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117158992 | CMS |
| Novo Nordisk Inc | $17.12 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096602239 | CMS |
| Novo Nordisk Inc | $16.88 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097715664 | CMS |
| PFIZER INC. | $15.72 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131103644 | CMS |
| PFIZER INC. | $14.66 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131303360 | CMS |
| PFIZER INC. | $15.43 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131406794 | CMS |
| PFIZER INC. | $16.16 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131767312 | CMS |
| PFIZER INC. | $15.14 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131884657 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.95 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151088705 | CMS |
| SANOFI PASTEUR INC. | $19.00 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128741762 | CMS |
| W. L. Gore & Associates, Inc. | $28.42 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148077735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.